India, Oct. 6 -- Shares of Jaguar Health (JAGX) moved higher after the company announced that its family company, Napo Pharmaceuticals, will sponsor an intestinal failure discussion at the 2nd Best of Elite Ped-GI pediatric gastroenterology meeting in Abu Dhabi on October 30.
The panel, titled " Intestinal Barrier Beyond Total Parenteral Nutrition (TPN)," will feature pediatric gastroenterology experts including Dr. Mohamad Miqdady, Dr. Christos Tzivinikos, and Pravin Chaturvedi, Napo's and Jaguar's Chief Scientific Officer.
The announcement comes as Napo continues to advance its global development program for crofelemer powder for oral solution as an adjunctive therapy for rare intestinal failure diseases, including microvillus inclusion...